Neurology and Therapy

Aims & Scope

Neurology and Therapy aims to provide reliable and inclusive, rapid publication for all therapy related research for neurological indications, supporting the timely dissemination of research with a global reach, to help advance scientific discovery and support clinical practice.

Neurology and Therapy is an international, open access, peer reviewed, rapid publication journal dedicated to the publication of high-quality clinical (all phases), observational, real-world and health outcomes research around the discovery, development, and use of neurological and psychiatric therapies, (also covering surgery and devices).

Studies relating to diagnosis, pharmacoeconomics, public health, quality of life, and patient care, management, and education are also welcomed.

The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, case reports, trial designs, communications and letters.

The journal is read by a global audience and receives submissions from all over the world.

Neurology and Therapy will consider all scientifically sound research be it positive, confirmatory or negative data.

Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations.

This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Neuroscience, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine and Neuroscience, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 4,700.00 GBP. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Alzheimer’s Disease: Epidemiology and Clinical Progression

  Citation: 385

  Authors: Amir Abbas, Michael J., Leigh Ann, Quanwu

• Vitamin D and Multiple Sclerosis: A Comprehensive Review

  Citation: 330

  Authors: Martina B., Mark, Anthony T.

• A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood

  Citation: 219

  Authors: Kaj

• A Review of Patisiran (ONPATTRO®) for the Treatment of Polyneuropathy in People with Hereditary Transthyretin Amyloidosis

  Citation: 192

  Authors: Ivan, Daniel, Michael C., Anjana, Kevin, Ariunzaya, Amnon A., Hisham, Alan D., Omar

• Mechanism of Action and Clinical Application of Tafamidis in Hereditary Transthyretin Amyloidosis

  Citation: 160

  Authors: Teresa, Giampaolo, Christine E., James A., Daniel P., Jeffery W., Mathew S., Violaine, Richard, Rajiv, Steve, Ilise, Pedro

• Hematoma Evacuation via Image-Guided Para-Corticospinal Tract Approach in Patients with Spontaneous Intracerebral Hemorrhage

  Citation: 141

  Authors: Chao, Hongfei, Shuixian, Dan, Zhouyang, Chuan, Lan, Hua, Rong

• Deep Learning and Neurology: A Systematic Review

  Citation: 132

  Authors: Aly Al-Amyn, Daniel, Eric Karl

• An Update on Blood-Based Markers of Alzheimer’s Disease Using the SiMoA Platform

  Citation: 118

  Authors: Danni, Michelle M.

• Fingolimod Rebound: A Review of the Clinical Experience and Management Considerations

  Citation: 113

  Authors: Brian, April A., Jessica, Carlo

• Neurophysiological Markers of Alzheimer’s Disease: Quantitative EEG Approach

  Citation: 108

  Authors: Una, Vesna